These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors. Yarows SA JAMA; 2003 Apr 23-30; 289(16):2068-9; author reply 2069-70. PubMed ID: 12709458 [No Abstract] [Full Text] [Related]
3. From Tritace to Tri-Plen - the South African journey. Cardiovasc J Afr; 2009; 20(1):69-70. PubMed ID: 19287820 [No Abstract] [Full Text] [Related]
4. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors. Messerli FH; Weber MA JAMA; 2003 Apr 23-30; 289(16):2067-8; author reply 2069-70. PubMed ID: 12709457 [No Abstract] [Full Text] [Related]
5. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors. Ong HT JAMA; 2003 Apr 23-30; 289(16):2068; author reply 2069-70. PubMed ID: 12709460 [No Abstract] [Full Text] [Related]
6. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors. Chikamori T JAMA; 2003 Apr 23-30; 289(16):2066; author reply 2069-70. PubMed ID: 12709456 [No Abstract] [Full Text] [Related]
7. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
8. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors. Palmer CR; Brown MJ; Mancia G; Ruilope LM; JAMA; 2003 Apr 23-30; 289(16):2066-7; author reply 2069-70. PubMed ID: 12709455 [No Abstract] [Full Text] [Related]
9. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors. Rifkin W JAMA; 2003 Apr 23-30; 289(16):2068; author reply 2069-70. PubMed ID: 12709459 [No Abstract] [Full Text] [Related]
10. Does it matter how hypertension is controlled? Chobanian AV N Engl J Med; 2008 Dec; 359(23):2485-8. PubMed ID: 19052130 [No Abstract] [Full Text] [Related]
11. Cardiovascular outcomes and antihypertensive drug treatment in older women. Bursztyn M JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811971 [No Abstract] [Full Text] [Related]
12. Cardiovascular outcomes and antihypertensive drug treatment in older women. Staessen JA; Thijs L; Wang J; Li Y JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811972 [No Abstract] [Full Text] [Related]
13. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors. Rollins G Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699 [No Abstract] [Full Text] [Related]
15. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients. Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181 [No Abstract] [Full Text] [Related]
16. Antihypertensive drugs and fibrinolytic function. Fogari R; Zoppi A Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777 [TBL] [Abstract][Full Text] [Related]
17. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention. Talbert RL J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609 [TBL] [Abstract][Full Text] [Related]